![UC San Diego, the University of Florida, and two Ohio universities are among academic institutes making investments to bridge the gap between benchtop research and new drug development. [NiDerLander - Fotolia.com]](http://www.innovationamerica.us/media/Administrator/Scientist958091694.png "Scientist.png")
This summer the Regents of the University of California can expect to be formally presented with plans by University of California, San Diego for a $110 million research center designed to speed up development of new treatments by the university and its industry partners. UC San Diego expects the Center for Novel Therapeutics (CNT) to promote interaction between private company researchers and their university counterparts based at nearby clinical facilities, namely UC San Diego Moores Cancer Center and the UC San Diego Health Sciences campus.
“There’s a huge gap between the discovery at the bench and the application of the discovery and development of a new therapeutic,” Thomas Kipps, M.D., Ph.D., the cancer center’s interim director, pointed out to GEN. “And this is intended to make that gap a little less onerous to bridge.”
To read the full, original article click on this link: GEN | Insight & Intelligence™: Academia Increasingly Going Beyond Basic Research by Setting Up Translational Med Centers
